The U.S. Food and Drug Administration is warning women about a screening commonly performed during pregnancy. Non-invasive prenatal screening tests carry a risk of false results, the FDA said in a ...

UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution. Transgender women on hormone therapy tend to skew artificially low on prostate cancer ...

Currently the screening is offered to women and people with a cervix aged 25 to 64. Depending on your age and where you live you will be issued an invite every three to five years.

The newly approved at-home screening device “could be an important tool in getting more women regularly screened, especially those that don’t have access to a medical provider,” Vaidya said.

The U.S. Food and Drug Administration is warning women about a screening commonly performed during pregnancy. Non-invasive prenatal screening tests carry a risk of false results, the FDA said in a ...

The newly approved at-home screening device “could be an important tool in getting more women regularly screened, especially those that don’t have access to a medical provider,” Vaidya said.